Valued at $136.0M at its later-stage round, Aug 2025. Nothing has traded since.
- ·Watch BioConsortia: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
BioConsortia funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2023 | Early Stage VC | $15.0M | ▮ | ▮ |
| Mar 2019 | Early Stage VC | $8.0M | ▮ | ▮ |
| Mar 2018 | Early Stage VC | $10.0M | ▮ | ▮ |
| Oct 2016 | Early Stage VC | $8.0M | ▮ | ▮ |
Membership and data by Private Market View
BioConsortia valuation
BioConsortia was valued at $136 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has BioConsortia raised?
BioConsortia has raised $79 million across 4 recorded rounds since 2016. The largest was an $8 million early-stage round in Mar 2019; the most recent was a $15 million early-stage round in Apr 2023.
BioConsortia has filed 5 Form Ds with the SEC since 2016, most recently in Apr 2023 ($15 million sold to 1 investor).
How BioConsortia's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For BioConsortia, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about BioConsortia
- What is BioConsortia worth?
- BioConsortia is valued at $136.0M as of Oct 2026. Valued at $136.0M at its later-stage round, Aug 2025. Nothing has traded since.
- How much has BioConsortia raised?
- BioConsortia has raised $79.0M in total funding across 4 recorded rounds.
- When did BioConsortia last raise?
- BioConsortia last raised in Apr 2023 (Early Stage VC), raising $15.0M.